Update in thrombolytic therapy

Revue Neurologique

Volumn 155, Issue 9, 1999, Pages 662-665

  Hacke, W ^a   Ringleb, P ^a   Stingele, R ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; FIBRINOLYTIC AGENT; STREPTOKINASE;

BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; FIBRINOLYTIC THERAPY; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; META ANALYSIS; MORTALITY; RISK BENEFIT ANALYSIS; STROKE; TREATMENT INDICATION; TREATMENT OUTCOME;

CEREBROVASCULAR ACCIDENT; CLINICAL TRIALS; HUMANS; RECOMBINANT PROTEINS; STREPTOKINASE; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR;

EID: 0032873522     PISSN: 00353787     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (15)

1. DEL ZOPPO GJ, ZEUMER H, MARKER LA (1986) Thrombolytic therapy in stroke: possibilities and hazards. Stroke 17: 595-607.
2. DEL ZOPPO GJ, PESSIN MS, MORI E, et al (1991) Thrombolytic intervention in acute thrombotic and embolie stroke. Sem Neural 11 (4): 368-84.
3. DONNAN GA, DAVIS SM, CHAMBERS, et al (1995) Trials of streptokinase in acute ischémie stroke. Lancet 345:578-9.
4. HACKE W, ZEUMER H, FERBERT A, et al (1988) Intra-arterial thrombolytic therapy improves outcome in patients with acute vertebrobasilar occlusive disease. Stroke 19:1216-22.
5. HACKE W (1994) Thrombolytic therapy in acute ischémie stroke an update. Fibrinolysis 8 (Suppl 1): 216-20.
6. HACKE W, KASTE M, FIESCHI C, et al (1995) Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS). JAMA 274:1017-25.
7. HACKE W, KASTE M, RESCHI C, et al for thé second EuropeanAustralasian Acute Stroke Study Investigators (1998) Randomised double blind trial of thrombolytic therapy with intravenous alteplase in acute ischémie stroke (ECASS II). Lancet 352: 1245-1251.
8. HALEY EC Jr (1993) Thrombolytic therapy for acute ischémie stroke. Clin Neuropharmacol 16:179-94.
9. MORI E, YONEDA Y, TABUCHI M, et al (1992) Intravenous recombinant tissue plasminogen activator in acute carotid artery territory stroke. Neurology 42: 976-82.
10. MULTICENTRE ACUTE STROKE TRIAL - ITALY (MAST-I) Group (1995). Randomized controlled trial of streptokinase, aspirin and combination of both in acute ischémie stroke. Lancet 346:1509-14.
11. THE MULTICENTER ACUTE STROKE TRIAL EUROPE STUDY GROUP (1996). Thrombolytic therapy with streptokinase in acute isché mie stroke. N Engt J Med 335:145-50.
12. THE NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE RTPA STROKE STUDY GROUP (1995). Tissue plasminogen activator for acute ischémie stroke. N Engl J Med 333:1581-7.
13. VON KUMMER R, MEYDING-LAMADé U, FORSTING M, et al (1994) Sensitivity and prognostic value of early CT in occlusion of the middle cerebral artery trunk. Am J Neuroradiol 15: 9-15.
14. WOO KS, WHITE HD (1993) Comparative tolerability profiles of thrombolytic agents. Drug Safety 8:19-29.
15. YAMAGUCHI T, HAYAKAWA T, KIKICHI H, et al (1991) Intravenous rtPA in acute embolie stroke; In Hacke W, Del Zoppo GJ, Hirschberg M, eds Thrombolytic therapy in acute ischémie stroke, pp 68-74, Springer Verlag, Berlin.